THERF at new 52 week high. Mentioned this several months ago in the $2's. Company should get second approval for their new drug. Big market. Company has break through designation and orphan drug for this new one. Very undervalued.
"Don't worry about the world coming to an end today. It's already tomorrow in Australia"
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.